Skip to content

Evaluation of the Coping Long Term With Active Suicide Program

Evaluation of the Coping Long Term With Active Suicide Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02313753
Acronym
CLASP
Enrollment
224
Registered
2014-12-10
Start date
2014-12-31
Completion date
2021-03-31
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suicide

Brief summary

The purpose of this study is to evaluate the utility of the Coping Long Term with Active Suicide Program (CLASP) for reducing suicidal behavior.

Interventions

BEHAVIORALCLASP
BEHAVIORALSAFE

Sponsors

Butler Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Current patient at Butler Hospital 2. Suicide attempt or suicidal ideation with intent to make a suicide attempt within 48 hours of hospitalization as indicated on the hospital chart and confirmed by administration of the C-SSRS 3. Age \> 18 years 4. Have a reliable telephone 5. Ability to speak, read, and understand English well to complete the procedures of the study

Exclusion criteria

1. Current psychotic symptoms severe enough to impair study participation 2. Participation in a treatment program with established efficacy in preventing suicidal behavior 3. Cognitive impairment which would interfere with adequate participation in the project (MMSE\< 20). 4\. Currently in state custody or pending legal action 5. Already enrolled current or previous CLASP trial

Design outcomes

Primary

MeasureTime frameDescription
A composite composed of the number of participants with either a suicide attempt or death by suicide52 weeks following discharge from hospitalAs assessed by both the Columbia Suicide Severity Rating Scale and record review

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026